Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA To Investigate Role Of Context Of Risk Information In DTC Print Ads

This article was originally published in The Pink Sheet Daily

Executive Summary

Agency will undertake two consumer studies to determine possible options for improving communication of risk information in ads.

You may also be interested in...



FDA Goes Online For DTC Brief Summary Research

The agency’s computer-based direct-to-consumer advertising study will allow FDA to learn how much time consumers spend reading the brief summary.

FDA Releases DTC Guidances; "Not The Last Word" On Ads, Commissioner McClellan Says

The agency pledges further review of its guidance on direct-to-consumer advertising. Broadcast ads for drugs and enforcement actions against repeat offenders could see more attention.

GAO Urges Congress To Place EPO, Other Dialysis Services In Bundled Rates

The Government Accountability Office recommends that Congress establish a bundled payment system for end-stage renal disease services - including Amgen's Epogen (epoetin) - under Medicare Part B "as soon as possible.

Topics

UsernamePublicRestriction

Register

PS064061

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel